TLR2 and chronic obstructive pulmonary disease: Taken together, these results suggest that the TLR2 and c-jun-mediated immune responses toward PA infection are impaired in alveolar macrophages from COPD subjects, and although treatment with corticosteroids FLU and BUD may rescue the response in COPD, these drugs have no effect in COPD individuals under ICS baseline treatment.